Clinical Trials Logo
  1. Home
  2. Lichen Planus
  3. NCT05030415

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

Lichen Planus Clinical Trial

Official title:
A Proof of Concept, Non-randomized, One Center Study to Explore the Safety and Efficacy of 16 Weeks of Treatment With Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

Clinical Trial Summary

To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).

Clinical Trial Description

A proof of concept, non-randomized, one center study to explore the safety and efficacy of 16 weeks of treatment with ixekizumab in adult patients with lichen planus. The total study period will consist of 24 weeks including a 2 week screening/washout, 16 weeks of active therapy and 8 weeks of follow up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05030415
Study type Interventional
Source University of New Mexico
Contact
Status Completed
Phase Early Phase 1
Start date August 12, 2021
Completion date March 25, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06021405 - Koebner's Phenomenon in Psoriasis and Lichen Planus N/A
Recruiting NCT03340155 - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases N/A
Completed NCT05787925 - Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus N/A
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Completed NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Recruiting NCT04697563 - Laser Therapy in Women With Lichenoid Disorders N/A
Recruiting NCT06451744 - Cellular and Molecular Biomarkers in Patients With Lichen Planus N/A
Completed NCT03265093 - Use of Injectable Platelet Rich Fibrin in Lichen Planus N/A
Completed NCT03858634 - A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases Phase 2
Completed NCT02761122 - Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen) N/A
Active, not recruiting NCT00691106 - A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus Phase 2
Terminated NCT05761158 - Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
Recruiting NCT02261662 - Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection N/A
Not yet recruiting NCT04892381 - Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Recruiting NCT02532166 - Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus N/A
Recruiting NCT06327620 - Treatment Of Oral Lichen Planus N/A
Completed NCT03796806 - Methods Validation Assessment for Study of Inflammatory Skin Disease
Completed NCT02850601 - Dexamethasone Solution for the Treatment of Oral Lichen Planus Phase 2
Not yet recruiting NCT01041625 - Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus Phase 2